Dr. Abidi Pharmaceutical Laboratories (DABID) overhead costs
What makes up manufacturing overhead
Fundamental analysis of DABID on Fundai: DABID Fundamental Analysis, Mehr 1405: Profit Forecast and Valuation
- Ticker
- DABID
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Salaries and wages expense | 25,361,097 | 5,528,951 | 2,989,333 | 2,031,969 | 1,130,465 | 630,732 |
| Depreciation expense | 1,161,876 | 909,875 | 640,965 | 504,045 | 311,098 | 170,740 |
| Energy expense (water, electricity, gas and fuel) | 220,449 | 131,459 | 70,700 | 54,214 | 53,969 | 14,467 |
| Consumable materials expense | 2,923,604 | 1,709,089 | 1,064,810 | 536,655 | 305,290 | 230,902 |
| Transportation and transfer expense | 1,109,345 | 618,943 | 380,458 | 259,616 | 114,297 | 44,606 |
| Other expenses | 3,419,597 | 2,585,295 | 2,624,104 | 1,485,112 | 747,953 | 404,846 |
| Total | 34,195,968 | 11,486,288 | 7,770,370 | 4,871,611 | 2,663,072 | 1,517,692 |
Reporting periods
34 periods are on file for this report, from the period ending 1396/09/30 to the period ending 1405/06/31.